Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3134)
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
31,641
Price
$292.06
Total Value
$9.24M
Shares Held After
27,696
% of Holdings
53.3%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
10,803
Price
$120.04
Total Value
$1.30M
Shares Held After
194,001
% of Holdings
5.3%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
46,387
Price
$10.37
Total Value
$481.03K
Shares Held After
1,319,784
% of Holdings
3.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
223
Price
$180.57
Total Value
$40.27K
Shares Held After
93,433
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
144
Price
$180.00
Total Value
$25.92K
Shares Held After
93,656
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
223
Price
$180.57
Total Value
$40.27K
Shares Held After
170,569
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
142
Price
$180.00
Total Value
$25.56K
Shares Held After
170,792
% of Holdings
0.1%
Wave Life Sciences, Inc. (WVE)
Rawcliffe Adrian — Director
Shares
12,700
Price
$5.29
Total Value
$67.18K
Shares Held After
0
% of Holdings
100.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
6,700
Price
$26.08
Total Value
$174.77K
Shares Held After
119,289
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
41
Price
$520.96
Total Value
$21.36K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
679
Price
$520.38
Total Value
$353.34K
Shares Held After
324,484
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$519.49
Total Value
$602.61K
Shares Held After
325,163
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$518.16
Total Value
$165.81K
Shares Held After
326,323
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,249
Price
$517.21
Total Value
$646.00K
Shares Held After
326,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
940
Price
$516.16
Total Value
$485.19K
Shares Held After
327,892
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
893
Price
$514.87
Total Value
$459.78K
Shares Held After
328,832
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
558
Price
$514.18
Total Value
$286.91K
Shares Held After
329,725
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$513.02
Total Value
$618.70K
Shares Held After
330,283
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
542
Price
$511.75
Total Value
$277.37K
Shares Held After
331,489
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,152
Price
$511.12
Total Value
$588.81K
Shares Held After
332,031
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$509.61
Total Value
$142.69K
Shares Held After
333,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$508.86
Total Value
$223.90K
Shares Held After
333,463
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$507.08
Total Value
$20.28K
Shares Held After
333,903
% of Holdings
0.0%
X4 Pharmaceuticals, Inc (XFOR)
Volpone John — President
Shares
24,576
Price
$4.44
Total Value
$109.23K
Shares Held After
265,305
% of Holdings
8.5%
Zai Lab Ltd (ZLAB)
Lis William — Director
Shares
8,506
Price
$25.00
Total Value
$212.65K
Shares Held After
41,931
% of Holdings
16.9%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
47,436
Price
$4.44
Total Value
$210.83K
Shares Held After
328,651
% of Holdings
12.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,102
Price
$359.12
Total Value
$5.06M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,899
Price
$358.41
Total Value
$7.49M
Shares Held After
14,102
% of Holdings
59.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,396
Price
$357.63
Total Value
$5.51M
Shares Held After
35,001
% of Holdings
30.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,515
Price
$356.43
Total Value
$896.43K
Shares Held After
50,397
% of Holdings
4.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,980
Price
$354.71
Total Value
$702.32K
Shares Held After
52,912
% of Holdings
3.6%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
11,048
Price
$27.25
Total Value
$301.06K
Shares Held After
92,211
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$8.50
Total Value
$42.50K
Shares Held After
1,361,053
% of Holdings
0.4%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
619
Price
$25.00
Total Value
$15.47K
Shares Held After
35,072
% of Holdings
1.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Chaudhuri Sarbani — Chief Commercial&Medical Affairs Officer
Shares
4,701
Price
$3.50
Total Value
$16.45K
Shares Held After
262,809
% of Holdings
1.8%
Wave Life Sciences, Inc. (WVE)
Wagner Heidi L — Director
Shares
7,000
Price
$6.01
Total Value
$42.07K
Shares Held After
44,930
% of Holdings
13.5%
Wave Life Sciences, Inc. (WVE)
Tan Aik Na — Director
Shares
432
Price
$6.01
Total Value
$2.60K
Shares Held After
24,968
% of Holdings
1.7%
Wave Life Sciences, Inc. (WVE)
TAKANASHI KEN — Director
Shares
3,864
Price
$6.01
Total Value
$23.22K
Shares Held After
20,079
% of Holdings
16.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
2,666
Price
$360.00
Total Value
$959.76K
Shares Held After
0
% of Holdings
100.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's title: EVP, Chief Medical Officer
Shares
8,300
Price
$26.52
Total Value
$220.13K
Shares Held After
119,289
% of Holdings
6.5%
Septerna, Inc. (SEPN)
Bhatt Elizabeth — President and COO
Shares
25,000
Price
$44.00
Total Value
$1.10M
Shares Held After
174,209
% of Holdings
12.5%
Denali Therapeutics Inc. (DNLI)
Schuth Alexander O. — COFO and Secretary
Shares
2,857
Price
$25.07
Total Value
$71.62K
Shares Held After
281,763
% of Holdings
1.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
368
Price
$13.96
Total Value
$5.14K
Shares Held After
145,937
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
1,775
Price
$13.96
Total Value
$24.78K
Shares Held After
704,781
% of Holdings
0.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Stevens Christopher James — Chief Operating Officer
Shares
36,658
Price
$3.50
Total Value
$128.27K
Shares Held After
505,784
% of Holdings
6.8%
Xenon Pharmaceuticals Inc. (XENE)
GANNON STEVEN — Director
Shares
10,000
Price
$64.06
Total Value
$640.55K
Shares Held After
1,870
% of Holdings
84.2%
Evogene Ltd. (EVGN)
RECANATI LEON — Director
Shares
460,000
Price
$0.64
Total Value
$292.10K
Shares Held After
1,343,886
% of Holdings
34.2%
Sagimet Biosciences Inc. (SGMT)
Kemble George — Director
Shares
20,206
Price
$9.95
Total Value
$201.15K
Shares Held After
62,161
% of Holdings
24.5%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,220
Price
$0.32
Total Value
$710.40
Shares Held After
34,199
% of Holdings
6.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
34,239
Price
$148.52
Total Value
$5.09M
Shares Held After
523,478
% of Holdings
6.1%
Showing 1301–1350 of 3134 transactions (page 27 of 63)